文献速递心脑血管急症复苏、休克与脓毒症

急诊医疗服务在年轻院外心脏骤停复苏后患者遗传学病因识别中的关键作用:MAP-IT 研究中期数据

The emergency medical service has a crucial role to unravel the genetics of sudden cardiac arrest in young, out of hospital resuscitated patients: Interim data from the MAP-IT study.
PubMed 文献 · Resuscitation · 2021-08-10
一句话结论EMS 在现场为年轻(1-50 岁)院外心脏骤停复苏患者留取血样,可提高遗传学病因检出率,助力家族一级/二级预防。

该前瞻性概念验证研究在德国两个县(562,904 居民)分析 39,506 次 EMS 出诊,纳入 1-50 岁需心肺复苏且非自然死亡者。769 次 CPR 中 103 例 <50 岁,24 例纳入基因分型;25% 携带(可能)致病性 ACMG-4/-5 变异,67% 携带意义不明变异(ACMG-3),其中 2 例经全外显子测序或家族史重新分类为 ACMG-4。结论:EMS 现场留取血样可提高致死性 OHCA 病例的遗传病因检出,有助于受影响家族的初级和二级预防。

要点

  • 在 1-50 岁非自然死亡、需 CPR 的 OHCA 患者中,EMS 现场留取血样送检可检出 ACMG-4/-5(可能)致病性变异(24 例中 25%)。
  • 基因分型患者中 67% 携带 ACMG-3 意义不明变异,其中 2 例经全外显子测序或家族史重新分类为 ACMG-4。
  • 769 次 CPR 占全部 EMS 出诊的 1.95%,CPR 发生率 68/100,000;<50 岁 CPR 共 103 例,58% 死于现场、26% 出院。
  • 纳入基因分型的 24 例中,33% 死于现场、37.5% 出院;EMS 对致死性 OHCA 病例的遗传病因识别贡献尤大。
  • 2021 ERC 指南推荐在未明确选择的病例中进行基因分析;EMS 现场留取高质量基因组 DNA 是后续 NGS 分子尸检的前提。

适用人群与场景

  • 德国两个县(562,904 居民)内 1-50 岁、需心肺复苏尝试的院外心脏骤停患者;排除非自然死亡病例。
  • EMS 现场场景,涵盖院外心脏骤停复苏全程,包括现场死亡与存活出院者。

诊断标准与关键阈值

  • 纳入标准:年龄 1-50 岁且需心肺复苏尝试;排除标准:非自然死亡。
  • 变异分类采用美国医学遗传学与基因组学学会(ACMG)指南:ACMG-4/-5 为(可能)致病性变异,ACMG-3 为意义不明变异。

处置流程与药物剂量

  • 第一步:EMS 在现场对符合年龄(1-50 岁)且需 CPR 的非自然死亡 OHCA 患者留取血样,保存生物材料供后续分子尸检。
  • 第二步:对留取样本进行配对末端 panel 测序(NGS),按 ACMG 指南对变异进行分类。
  • 第三步:对 ACMG-3 意义不明变异者,必要时行全外显子测序或结合家族史重新分类(原文 2 例重新分类为 ACMG-4)。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 前瞻性概念验证研究,德国两个县 562,904 居民,分析 39,506 次 EMS 出诊;769 次 CPR(占 1.95%,CPR 发生率 68/100,000)。
  • <50 岁 CPR 共 103 例:58% 死于现场、26% 出院;其中 24 例纳入基因分型:33% 死于现场、37.5% 出院。
  • 基因分型患者中 25% 携带 ACMG-4/-5(可能)致病性变异,67% 携带 ACMG-3 意义不明变异;2 例经全外显子测序或家族史重新分类为 ACMG-4。

证据类型、等级与局限

  • 证据类型:前瞻性概念验证研究(interim data),非随机对照。
  • 局限:样本量小(24 例基因分型)、仅两个德国县、为中期数据,原文未给出证据等级或推荐强度。

对床旁实践的改变

  • 支持 EMS 在现场对 1-50 岁非自然死亡 OHCA 患者常规留取血样,以增加遗传病因检出,助力家族筛查与预防。
  • 适用人群为 1-50 岁需 CPR 的 OHCA 患者;非自然死亡者不适用(原文排除)。
  • 常见陷阱:ACMG-3 意义不明变异占多数(67%),需全外显子测序或家族史辅助重新分类,不能仅凭 panel 结果下结论。

指南或共识出处

  • 2021 ERC 指南(原文提及推荐在未明确选择的病例中进行基因分析);MAP-IT 研究(Resuscitation 来源)。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Genetics of sudden cardiac deaths (SCD) remains frequently undetected. Genetic analysis is recommended in undefined selected cases in the 2021 ERC-guideline. The emergency medical service and physicians (EMS) may play a pivotal role for unraveling SCD by saving biomaterial for later molecular autopsy. Since for high-throughput DNA-sequencing (NGS) high quality genomic DNA is needed. We investigated in a prospective proof-of-concept study the role of the EMS for the identification of genetic forms of SCDs in the young.

METHODS: We included patients aged 1-50 years with need for cardiopulmonary resuscitation attempts (CPR). Cases with non-natural deaths were excluded. In two German counties with 562,904 residents 39,506 services were analysed. Paired end panel-sequencing was performed, and variants were classified according to guidelines of the American College of Medical Genetics (ACMG).

RESULTS: 769 CPR-attempts were recorded (1.95% of all EMS-services; CPR-incidence 68/100,000). In 103 cases CPR were performed in patients < 50y. 58% died on scene, 26% were discharged from hospital. 24 subjects were included for genotyping. Of these 33% died on scene, 37.5% were discharged from hospital. 25% of the genotyped patients were carriers of (likely) pathogenic (ACMG-4/-5) variants. 67% carried variants with unknown significance (ACMG-3). 2 of them had familial history for arrhythmogenic cardiomyopathy or had to be re-classified as ACMG-4 carriers due to whole exome sequencing.

CONCLUSION: The EMS contributes especially in fatal OHCA-cases to increase the yield of identified genetic conditions by collecting a blood sample on scene. Thus, the EMS can contribute significantly to primary and secondary prophylaxis in affected families.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Tiesmeier J, Gaertner A, Homm S, et al. The emergency medical service has a crucial role to unravel the genetics of sudden cardiac arrest in young, out of hospital resuscitated patients: Interim data from the MAP-IT study. Resuscitation. 2021. PMID: 34389451. doi:10.1016/j.resuscitation.2021.07.042

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。